Dataset Information

Control of magnetic contrast with nonlinear magneto-plasmonics.

ABSTRACT: The interaction between surface plasmons (SP) and magnetic behavior has generated great research interest due to its potential for future magneto-optical devices with ultra-high sensitivity and ultra-fast switching. Here we combine two surface sensitive effects: magnetic second-harmonic generation (MSHG) and SP to enhance the detection sensitivity of the surface magnetization in a single-crystal iron film. We show that the MSHG signal can be significantly enhanced by SP in an attenuated total reflection (ATR) condition, and that the magnetic contrast can be varied over a wide range by the angle-of-incidence. Furthermore, the magnetic contrast of transverse and longitudinal MSHG display opposite trends, which originates from the change of relative phase between MSHG components. This new effect enhances the sensing of magnetic switching, which has potential usage in quaternary magnetic storage systems and bio-chemical sensors due to its very high surface sensitivity and simple structure.

SUBMITTER: Zheng W

PROVIDER: S-EPMC4143786 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Control of magnetic contrast with nonlinear magneto-plasmonics.

Zheng Wei W Hanbicki Aubrey T AT Jonker Berend T BT Lüpke Gunter G

Scientific reports 20140826

The interaction between surface plasmons (SP) and magnetic behavior has generated great research interest due to its potential for future magneto-optical devices with ultra-high sensitivity and ultra-fast switching. Here we combine two surface sensitive effects: magnetic second-harmonic generation (MSHG) and SP to enhance the detection sensitivity of the surface magnetization in a single-crystal iron film. We show that the MSHG signal can be significantly enhanced by SP in an attenuated total re ...[more]

PMID: 25155873

Similar Datasets

Project description:Engineered cells used as smart vehicles for delivery of secreted therapeutic proteins enable effective treatment of cancer and certain degenerative, autoimmune, and genetic disorders. However, current cell-based therapies use mostly invasive tools for tracking proteins and do not allow for controlled secretion of therapeutic proteins, which could result in unconstrained killing of surrounding healthy tissues or ineffective killing of host cancer cells. Regulating the expression of therapeutic proteins after success of therapy remains elusive. In this study, a noninvasive therapeutic approach mediated by magneto-mechanical actuation (MMA) was developed to remotely regulate the expression of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein, which is secreted by transduced cells. Stem cells, macrophages, and breast cancer cells were transduced with a lentiviral vector encoding the SGpL2TR protein. SGpL2TR comprises TRAIL and GpLuc domains optimized for cell-based applications. Our approach relies on the remote actuation of cubic-shape highly magnetic field responsive superparamagnetic iron oxide nanoparticles (SPIONs) coated with nitrodopamine PEG (ND-PEG), which are internalized within the cells. Cubic ND-PEG-SPIONs actuated by superlow frequency alternating current magnetic fields can translate magnetic forces into mechanical motion and in turn spur mechanosensitive cellular responses. Cubic ND-PEG-SPIONs were artificially designed to effectively operate at low magnetic field strengths (<100 mT) retaining approximately 60% of their saturation magnetization. Compared to other cells, stems cells were more sensitive to the interaction with actuated cubic ND-PEG-SPIONs, which clustered near the endoplasmic reticulum (ER). Luciferase, ELISA, and RT-qPCR analyses revealed a marked TRAIL downregulation (secretion levels were depleted down to 30%) when intracellular particles at 0.100 mg/mL Fe were actuated by magnetic fields (65 mT and 50 Hz for 30 min). Western blot studies indicated actuated, intracellular cubic ND-PEG-SPIONs can cause mild ER stress at short periods (up to 3 h) of postmagnetic field treatment thus leading to the unfolded protein response. We observed that the interaction of TRAIL polypeptides with ND-PEG can also contribute to this response. To prove the applicability of our approach, we used glioblastoma cells, which were exposed to TRAIL secreted from stem cells. We demonstrated that in the absence of MMA treatment, TRAIL essentially killed glioblastoma cells indiscriminately, but when treated with MMA, we were able to control the cell killing rate by adjusting the magnetic doses. This approach can expand the capabilities of stem cells to serve as smart vehicles for delivery of therapeutic proteins in a controlled manner without using interfering and expensive drugs, while retaining their potential to regenerate damaged tissue after treatment. This approach brings forth new alternatives to regulate protein expression noninvasively for cell therapy and other cancer therapies.

Dataset Information

Control of magnetic contrast with nonlinear magneto-plasmonics.

Publications

Control of magnetic contrast with nonlinear magneto-plasmonics.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets